ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Clinical trials for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Living Drug' trial targets tough blood cancers
Disease control CompletedThis study tested a new treatment called anti-CD19 CAR-T cell therapy for adults with B-cell blood cancers like leukemia and lymphoma that had come back or not responded to other treatments. The therapy involves taking a patient's own immune cells, modifying them in a lab to bett…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: PHASE1, PHASE2 • Sponsor: National Research Center for Hematology, Russia • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
One donor, two transplants: experimental procedure aims to cure blood cancer and fix kidneys
Disease control CompletedThis pilot study tested a combined transplant from a partially matched family donor. It aimed to treat patients who had both a serious blood disorder (like leukemia) and advanced kidney disease at the same time. The goal was to cure the blood disorder and restore kidney function …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Fitness trackers fight fatigue: app helps young cancer patients get moving
Symptom relief CompletedThis study tested whether a mobile health program could help adolescents and young adults with acute lymphoblastic leukemia (ALL) reduce their sitting time during maintenance chemotherapy. Twenty participants used fitness trackers with movement reminders, received coaching, and j…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: NA • Sponsor: Children's Hospital Los Angeles • Aim: Symptom relief
Last updated Mar 16, 2026 15:26 UTC
-
A multicenter, randomized, phase III registration trial of transplantation of NiCord®, ex vivo expanded, UCB-derived, stem and progenitor cells, vs. unmanipulated UCB for patients with hematological malignancies
CompletedThis study is an open-label, controlled, multicenter, international, Phase III, randomized study of transplantation of NiCord® versus transplantation of one or two unmanipulated, unrelated cord blood units in patients with acute lymphoblastic leukemia or acute myeloid leukemia, m…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
Phase: PHASE3 • Sponsor: Gamida Cell ltd
Last updated Mar 02, 2026 15:25 UTC